My HPRA: Register

Braltus (tiotropium) - Important Safety Information from Teva Pharmaceuticals Ireland as approved by the HPRA

Notice type: 3rd Party Publications

Date: 06/01/2017

  

Problem Or Issue:
Important Safety Information communication from Teva Pharmaceuticals Ireland on advice to minimise the risk of medication error with Braltus (tiotropium).

« Back